Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO
Endpoints
Mon, 09/24/18 - 09:44 am
Tags:
PhaseBio, IPOs, PB2452, anti-anti-coagulants, AstraZeneca
Mon, 09/24/18 - 09:36 am
Tags:
AstraZeneca, Farxiga
AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times
Yahoo/Reuters
Sun, 09/23/18 - 01:47 pm
Tags:
UK, Brexit, AstraZeneca, Pascal Soriot, drug shortages
AZ expands role in China, to include robots and health tech
Pharmaforum
Thu, 09/20/18 - 10:03 am
Tags:
AstraZeneca, China, robotics, digital health, artificial intelligence
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
Fierce Pharma
Tue, 09/18/18 - 10:13 pm
Tags:
AstraZeneca, COPD, Fasenra, asthma
With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?
Fierce Pharma
Mon, 09/17/18 - 12:13 pm
Tags:
AstraZeneca, GSK, COPD, Trelegy Ellipta, PT010
AstraZeneca grabs an FDA OK for its new leukemia drug, to be marketed as Lumoxiti
Endpoints
Thu, 09/13/18 - 11:22 pm
Tags:
AstraZeneca, hairy cell leukemia, moxetumomab pasudotox
AstraZeneca plc (AZN) Expected to Post Earnings of $0.44 Per Share
Daily Political
Mon, 09/10/18 - 12:22 am
Tags:
AstraZeneca, earnings
Another setback for AstraZeneca as lupus drug fails phase 3 test
Fierce Biotech
Fri, 08/31/18 - 11:43 am
Tags:
AstraZeneca, SLE, systemic lupus erythematosus, lupus, anifrolumab, clinical trials
AstraZeneca improves diabetes pen to maintain its market share
Pharmaforum
Fri, 08/31/18 - 10:52 am
Tags:
Europe, AstraZeneca, Bydureon BCise, diabetes, injection pen
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
Mon, 08/27/18 - 10:02 am
Tags:
AbbVie, JNJ, FDA, Imbruvica, Rituxan, Roche, AstraZeneca, non-Hodgkin's lymphoma, Waldenström’s macroglobulinemia
Major Expected Events from AstraZeneca’s R&D in H2 2018
Market Realist
Sat, 08/25/18 - 09:24 pm
Tags:
AstraZeneca, China, Lynparza, Tagrisso, Imfinzi
AstraZeneca inhaler lags GSK drug in lung disease trial
Reuters
Thu, 08/23/18 - 11:54 am
Tags:
AstraZeneca, GSK, clinical trials, Bevespi Aerosphere, inhalers, COPD, Anoro
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
Tue, 08/21/18 - 10:08 am
Tags:
AstraZeneca, Japan, Tagrisso, non-small cell lung cancer
AstraZeneca, its new HQ delayed and way over budget, weighs a construction partner swap: report
Fierce Pharma
Mon, 08/20/18 - 10:41 pm
Tags:
AstraZeneca
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
Fierce Biotech
Mon, 08/20/18 - 10:09 am
Tags:
Entasis, IPOs, AstraZeneca, clinical trials, beta-lactams
PARP inhibitors show promise for treating ALS and other brain disorders
Fierce Biotech
Thu, 08/9/18 - 10:04 pm
Tags:
PARP inhibitors, AstraZeneca, Lynparza, Tesaro, Zejula, ALS
Drug firms fight US government’s Iraq corruption probe
Pharmaforum
Thu, 08/9/18 - 08:46 pm
Tags:
Iraq, DOJ, AstraZeneca, Roche, JNJ, GE, Pfizer
AstraZeneca to Pay $110 Million to Settle Texas Drug Suits
Yahoo/Bloomberg
Tue, 08/7/18 - 11:51 pm
Tags:
AstraZeneca, Texas, Medicaid
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Endpoints
Mon, 08/6/18 - 09:53 am
Tags:
AstraZeneca, gout, lesinurad, Ironwood

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.